APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aldult CAR T-cell Therapy

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Aldult CAR T-cell Therapy Industry Growth and Trends Forecast to 2032

2 May 202688 pages

Choose your research edition.

Industry ResearchAldult CAR T-cell Therapy Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Aldult CAR T-cell Therapy Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Aldult CAR T-cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aldult CAR T-cell Therapy Market Outlook and Growth Opportunities 2026185 pages · $4,250 USDMarket Analysis & ForecastGlobal Aldult CAR T-cell Therapy Market Analysis and Forecast 2026-2032240 pages · $4,950 USD

Market perspective

According to APO Research, the global Aldult CAR T-cell Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Aldult CAR T-cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Aldult CAR T-cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aldult CAR T-cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Aldult CAR T-cell Therapy market include Bristol Myers Squibb，BMS, Johnson & Johnson, Gilead Sciences, Novartis, JW Therapeutics, Imunopharm Technology Co., Ltd., CARsgen Therapeutics and Cartesian Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Aldult CAR T-cell Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Aldult CAR T-cell Therapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Aldult CAR T-cell Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Aldult CAR T-cell Therapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Aldult CAR T-cell Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Aldult CAR T-cell Therapy Market by Company

Bristol Myers Squibb，BMS

Johnson & Johnson

Gilead Sciences

Novartis

JW Therapeutics

Imunopharm Technology Co., Ltd.

CARsgen Therapeutics

Cartesian Therapeutics

Aldult CAR T-cell Therapy Segment by Type

CD19

BCMA

Others

Aldult CAR T-cell Therapy Segment by Application

Multiple Myeloma

B-Cell Lymphoma (BCL)

Acute Lymphoblastic Leukemia (ALL)

Others

Aldult CAR T-cell Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aldult CAR T-cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aldult CAR T-cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aldult CAR T-cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Aldult CAR T-cell Therapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Aldult CAR T-cell Therapy Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Aldult CAR T-cell Therapy Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Aldult CAR T-cell Therapy Market Share by Region (2021-2026) Table 4. Global Aldult CAR T-cell Therapy Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Aldult CAR T-cell Therapy Market Share by Region (2027-2032) Table 6. Global Aldult CAR T-cell Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Aldult CAR T-cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Aldult CAR T-cell Therapy Market Size Share by Type (2021-2026) Table 9. Global Aldult CAR T-cell Therapy Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Aldult CAR T-cell Therapy Market Size Share Forecasted by Type (2027-2032) Table 11. North America Aldult CAR T-cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Aldult CAR T-cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Aldult CAR T-cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Aldult CAR T-cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Aldult CAR T-cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Aldult CAR T-cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Aldult CAR T-cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Aldult CAR T-cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Aldult CAR T-cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Aldult CAR T-cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Aldult CAR T-cell Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Aldult CAR T-cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Aldult CAR T-cell Therapy Market Size Share by Application (2021-2026) Table 24. Global Aldult CAR T-cell Therapy Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Aldult CAR T-cell Therapy Market Size Share Forecasted by Application (2027-2032) Table 26. North America Aldult CAR T-cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Aldult CAR T-cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Aldult CAR T-cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Aldult CAR T-cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Aldult CAR T-cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Aldult CAR T-cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Aldult CAR T-cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Aldult CAR T-cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Aldult CAR T-cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Aldult CAR T-cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Aldult CAR T-cell Therapy Industry Trends Table 37. Aldult CAR T-cell Therapy Industry Drivers Table 38. Aldult CAR T-cell Therapy Industry Opportunities and Challenges Table 39. Aldult CAR T-cell Therapy Industry Restraints Table 40. Global Aldult CAR T-cell Therapy Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Aldult CAR T-cell Therapy Revenue Market Share by Company (2021-2026) Table 42. Global Aldult CAR T-cell Therapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Aldult CAR T-cell Therapy Key Company Headquarters & Area Served Table 44. Global Aldult CAR T-cell Therapy Company, Product Type & Application Table 45. Global Aldult CAR T-cell Therapy Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Aldult CAR T-cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Bristol Myers Squibb，BMS Company Information Table 49. Bristol Myers Squibb，BMS Business Overview Table 50. Bristol Myers Squibb，BMS Aldult CAR T-cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Bristol Myers Squibb，BMS Aldult CAR T-cell Therapy Product Portfolio Table 52. Bristol Myers Squibb，BMS Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Aldult CAR T-cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Johnson & Johnson Aldult CAR T-cell Therapy Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. Gilead Sciences Company Information Table 59. Gilead Sciences Business Overview Table 60. Gilead Sciences Aldult CAR T-cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Gilead Sciences Aldult CAR T-cell Therapy Product Portfolio Table 62. Gilead Sciences Recent Development Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Aldult CAR T-cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Novartis Aldult CAR T-cell Therapy Product Portfolio Table 67. Novartis Recent Development Table 68. JW Therapeutics Company Information Table 69. JW Therapeutics Business Overview Table 70. JW Therapeutics Aldult CAR T-cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. JW Therapeutics Aldult CAR T-cell Therapy Product Portfolio Table 72. JW Therapeutics Recent Development Table 73. Imunopharm Technology Co., Ltd. Company Information Table 74. Imunopharm Technology Co., Ltd. Business Overview Table 75. Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Product Portfolio Table 77. Imunopharm Technology Co., Ltd. Recent Development Table 78. CARsgen Therapeutics Company Information Table 79. CARsgen Therapeutics Business Overview Table 80. CARsgen Therapeutics Aldult CAR T-cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. CARsgen Therapeutics Aldult CAR T-cell Therapy Product Portfolio Table 82. CARsgen Therapeutics Recent Development Table 83. Cartesian Therapeutics Company Information Table 84. Cartesian Therapeutics Business Overview Table 85. Cartesian Therapeutics Aldult CAR T-cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Cartesian Therapeutics Aldult CAR T-cell Therapy Product Portfolio Table 87. Cartesian Therapeutics Recent Development Table 88. North America Aldult CAR T-cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. North America Aldult CAR T-cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 90. North America Aldult CAR T-cell Therapy Market Share by Country (2021-2026) Table 91. North America Aldult CAR T-cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. North America Aldult CAR T-cell Therapy Market Share Forecast by Country (2027-2032) Table 93. Europe Aldult CAR T-cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Europe Aldult CAR T-cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 95. Europe Aldult CAR T-cell Therapy Market Share by Country (2021-2026) Table 96. Europe Aldult CAR T-cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Europe Aldult CAR T-cell Therapy Market Share Forecast by Country (2027-2032) Table 98. Asia-Pacific Aldult CAR T-cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Asia-Pacific Aldult CAR T-cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 100. Asia-Pacific Aldult CAR T-cell Therapy Market Share by Country (2021-2026) Table 101. Asia-Pacific Aldult CAR T-cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Asia-Pacific Aldult CAR T-cell Therapy Market Share Forecast by Country (2027-2032) Table 103. Latin America Aldult CAR T-cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Latin America Aldult CAR T-cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 105. Latin America Aldult CAR T-cell Therapy Market Share by Country (2021-2026) Table 106. Latin America Aldult CAR T-cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Latin America Aldult CAR T-cell Therapy Market Share Forecast by Country (2027-2032) Table 108. Middle East & Africa Aldult CAR T-cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Middle East & Africa Aldult CAR T-cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 110. Middle East & Africa Aldult CAR T-cell Therapy Market Share by Country (2021-2026) Table 111. Middle East & Africa Aldult CAR T-cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Middle East & Africa Aldult CAR T-cell Therapy Market Share Forecast by Country (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Aldult CAR T-cell Therapy Product Image Figure 3. Global Aldult CAR T-cell Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Aldult CAR T-cell Therapy Market Size (2021-2032) & (US$ Million) Figure 5. Global Aldult CAR T-cell Therapy Market Share by Region: 2025 VS 2032 Figure 6. Global Aldult CAR T-cell Therapy Market Share by Region (2021-2032) Figure 7. North America Aldult CAR T-cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Aldult CAR T-cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Aldult CAR T-cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Aldult CAR T-cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Aldult CAR T-cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. CD19 Image Figure 13. Global CD19 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. BCMA Image Figure 15. Global BCMA Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Aldult CAR T-cell Therapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Aldult CAR T-cell Therapy Market Share by Type 2025 VS 2032 Figure 20. North America Aldult CAR T-cell Therapy Market Size Share by Type (2021-2032) Figure 21. Europe Aldult CAR T-cell Therapy Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Aldult CAR T-cell Therapy Market Size Share by Type (2021-2032) Figure 23. Latin America Aldult CAR T-cell Therapy Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Aldult CAR T-cell Therapy Market Size Share by Type (2021-2032) Figure 25. Multiple Myeloma Image Figure 26. Global Multiple Myeloma Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. B-Cell Lymphoma (BCL) Image Figure 28. Global B-Cell Lymphoma (BCL) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Acute Lymphoblastic Leukemia (ALL) Image Figure 30. Global Acute Lymphoblastic Leukemia (ALL) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Aldult CAR T-cell Therapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Aldult CAR T-cell Therapy Market Share by Application 2025 VS 2032 Figure 35. North America Aldult CAR T-cell Therapy Market Size Share by Application (2021-2032) Figure 36. Europe Aldult CAR T-cell Therapy Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Aldult CAR T-cell Therapy Market Size Share by Application (2021-2032) Figure 38. Latin America Aldult CAR T-cell Therapy Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Aldult CAR T-cell Therapy Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Aldult CAR T-cell Therapy Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Aldult CAR T-cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Aldult CAR T-cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Aldult CAR T-cell Therapy Market Share by Country (2021-2032) Figure 45. Europe Aldult CAR T-cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Aldult CAR T-cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Aldult CAR T-cell Therapy Market Share by Country (2021-2032) Figure 48. Asia-Pacific Aldult CAR T-cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Aldult CAR T-cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Aldult CAR T-cell Therapy Market Share by Country (2021-2032) Figure 51. Latin America Aldult CAR T-cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Aldult CAR T-cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Aldult CAR T-cell Therapy Market Share by Country (2021-2032) Figure 54. Middle East & Africa Aldult CAR T-cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Aldult CAR T-cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Aldult CAR T-cell Therapy Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • CD19
  • BCMA
  • Others
Applications
  • Multiple Myeloma
  • B-Cell Lymphoma (BCL)
  • Acute Lymphoblastic Leukemia (ALL)
  • Others
Companies covered
  • Bristol Myers Squibb，BMS
  • Johnson & Johnson
  • Gilead Sciences
  • Novartis
  • JW Therapeutics
  • Imunopharm Technology Co., Ltd.
  • CARsgen Therapeutics
  • Cartesian Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Aldult CAR T-cell Therapy Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Aldult CAR T-cell Therapy Market Size by Region (2021-2032)
  5. 1.4.1 Global Aldult CAR T-cell Therapy Market Size by Region (2021-2026)
  6. 1.4.2 Global Aldult CAR T-cell Therapy Market Size by Region (2027-2032)
  7. 1.5 Key Regions Aldult CAR T-cell Therapy Market Size (2021-2032)
  8. 1.5.1 North America Aldult CAR T-cell Therapy Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Aldult CAR T-cell Therapy Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Aldult CAR T-cell Therapy Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Aldult CAR T-cell Therapy Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Aldult CAR T-cell Therapy Market Size Growth Rate (2021-2032)
2 Aldult CAR T-cell Therapy Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 CD19
  3. 2.1.2 BCMA
  4. 2.1.3 Others
  5. 2.2 Global Aldult CAR T-cell Therapy Market Size by Type
  6. 2.2.1 Global Aldult CAR T-cell Therapy Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Aldult CAR T-cell Therapy Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Aldult CAR T-cell Therapy Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Aldult CAR T-cell Therapy Market Size by Regions
  10. 2.3.1 North America Aldult CAR T-cell Therapy Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Aldult CAR T-cell Therapy Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Aldult CAR T-cell Therapy Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Aldult CAR T-cell Therapy Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Aldult CAR T-cell Therapy Market Size Breakdown by Type (2021-2026)
3 Aldult CAR T-cell Therapy Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Multiple Myeloma
  3. 3.1.2 B-Cell Lymphoma (BCL)
  4. 3.1.3 Acute Lymphoblastic Leukemia (ALL)
  5. 3.1.4 Others
  6. 3.2 Global Aldult CAR T-cell Therapy Market Size by Application
  7. 3.2.1 Global Aldult CAR T-cell Therapy Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Aldult CAR T-cell Therapy Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Aldult CAR T-cell Therapy Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Aldult CAR T-cell Therapy Market Size by Regions
  11. 3.3.1 North America Aldult CAR T-cell Therapy Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Aldult CAR T-cell Therapy Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Aldult CAR T-cell Therapy Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Aldult CAR T-cell Therapy Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Aldult CAR T-cell Therapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Aldult CAR T-cell Therapy Industry Trends
  2. 4.2 Aldult CAR T-cell Therapy Industry Drivers
  3. 4.3 Aldult CAR T-cell Therapy Industry Opportunities and Challenges
  4. 4.4 Aldult CAR T-cell Therapy Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Aldult CAR T-cell Therapy Revenue (2021-2026)
  2. 5.2 Global Aldult CAR T-cell Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Aldult CAR T-cell Therapy Key Company Headquarters & Area Served
  4. 5.4 Global Aldult CAR T-cell Therapy Company, Product Type & Application
  5. 5.5 Global Aldult CAR T-cell Therapy Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Aldult CAR T-cell Therapy Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Aldult CAR T-cell Therapy Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Aldult CAR T-cell Therapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Bristol Myers Squibb，BMS
  2. 6.1.1 Bristol Myers Squibb，BMS Company Information
  3. 6.1.2 Bristol Myers Squibb，BMS Business Overview
  4. 6.1.3 Bristol Myers Squibb，BMS Aldult CAR T-cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Bristol Myers Squibb，BMS Aldult CAR T-cell Therapy Product Portfolio
  6. 6.1.5 Bristol Myers Squibb，BMS Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Aldult CAR T-cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Aldult CAR T-cell Therapy Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Gilead Sciences
  14. 6.3.1 Gilead Sciences Company Information
  15. 6.3.2 Gilead Sciences Business Overview
  16. 6.3.3 Gilead Sciences Aldult CAR T-cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Gilead Sciences Aldult CAR T-cell Therapy Product Portfolio
  18. 6.3.5 Gilead Sciences Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Aldult CAR T-cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Aldult CAR T-cell Therapy Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 JW Therapeutics
  26. 6.5.1 JW Therapeutics Company Information
  27. 6.5.2 JW Therapeutics Business Overview
  28. 6.5.3 JW Therapeutics Aldult CAR T-cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 JW Therapeutics Aldult CAR T-cell Therapy Product Portfolio
  30. 6.5.5 JW Therapeutics Recent Developments
  31. 6.6 Imunopharm Technology Co., Ltd.
  32. 6.6.1 Imunopharm Technology Co., Ltd. Company Information
  33. 6.6.2 Imunopharm Technology Co., Ltd. Business Overview
  34. 6.6.3 Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Product Portfolio
  36. 6.6.5 Imunopharm Technology Co., Ltd. Recent Developments
  37. 6.7 CARsgen Therapeutics
  38. 6.7.1 CARsgen Therapeutics Company Information
  39. 6.7.2 CARsgen Therapeutics Business Overview
  40. 6.7.3 CARsgen Therapeutics Aldult CAR T-cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 CARsgen Therapeutics Aldult CAR T-cell Therapy Product Portfolio
  42. 6.7.5 CARsgen Therapeutics Recent Developments
  43. 6.8 Cartesian Therapeutics
  44. 6.8.1 Cartesian Therapeutics Company Information
  45. 6.8.2 Cartesian Therapeutics Business Overview
  46. 6.8.3 Cartesian Therapeutics Aldult CAR T-cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Cartesian Therapeutics Aldult CAR T-cell Therapy Product Portfolio
  48. 6.8.5 Cartesian Therapeutics Recent Developments
7 North America
  1. 7.1 North America Aldult CAR T-cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Aldult CAR T-cell Therapy Market Size by Country (2021-2026)
  3. 7.3 North America Aldult CAR T-cell Therapy Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Aldult CAR T-cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Aldult CAR T-cell Therapy Market Size by Country (2021-2026)
  3. 8.3 Europe Aldult CAR T-cell Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Aldult CAR T-cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Aldult CAR T-cell Therapy Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Aldult CAR T-cell Therapy Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Aldult CAR T-cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Aldult CAR T-cell Therapy Market Size by Country (2021-2026)
  3. 10.3 South America Aldult CAR T-cell Therapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Aldult CAR T-cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Aldult CAR T-cell Therapy Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Aldult CAR T-cell Therapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst